FDA Approval: Siltuximab for the Treatment of Patients with Multicentric Castleman Disease
Year: 2015
Type: article
Source: Clinical Cancer Research
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2169461745
